Bioterrorism Week articles from June 2004

Bioterrorism Week archives from June 2004

Vaccines for infectious diseases with cutaneous symptoms reviewed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists review vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations in a recent issue of the Journal of the American Academy of Dermatology. ...

New network will research fatal reactions to smallpox vaccine.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The National Institute of Allergy and Infectious Diseases (NIAID) has announced the formation of a new research group to reduce the risk of a severe and potentially deadly complication of the smallpox...

Anthim selected for testing by U.S. federal government.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Elusys Therapeutics, Inc., announced that its anti-anthrax antibody, trade name Anthim(ETI-204), was selected by the U.S. Centers for Disease Control and Prevention (CDC) for evaluation by the...

Conjugate induces antibodies to capsule of B. anthracis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Immunization with a synthetic peptide-carrier protein conjugate induces opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis. "The capsule of Bacillus anthracis, a polymer...

U.S. Department of Homeland Security awards $7.5M biodefense contract.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- U.S. Genomics has been awarded a $7.5 million phase I contract by the U.S. Department of Homeland Security Advanced Research Project Agency (HSARPA) to develop a sophisticated biological sensor for...

Bioterror vaccine maker partners with biotech company for $2M deal.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced that it has been awarded a new multi-study clinical research program with a top-tier biopharmaceutical company. The initial contract within this program is for...

Antigen Express wins Japanese patent for certain Ii-Key compounds.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced the award of Japan patent 3534761 to its Antigen Express affiliate for certain Ii-Key immunologically active compounds and their use in modifying immune...

Beta-catenin signaling acts differently in prostatic or colorectal tumorigenesis.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The beta-catenin signaling pathway acts differently in prostatic and colorectal tumorigenesis. "We studied 101 prostatic adenocarcinomas (72 acinar, 29 ductal) and 16 cases with high-grade...

Research into parasite movement may help fight malaria.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers at the University of North Carolina at Chapel Hill have discovered a new protein in the cell wall of parasites that helps them move between cells and cause diseases such as malaria. The...

$1M contract signed to study vaccine against plague.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced the signing of its third counter-bioterrorism vaccines contract within the past 5 months. This $1.0 million contract with DynPort Vaccine Company LLC (DVC) is...

Smallpox vaccine adverse effects linked to cytokine level alterations.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. According to a study from the United States, "The immunization of healthy adults with...

Company unveils technology for collection of biohazardous materials.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Microbial-Vac Systems, Inc., (MSI), a developer of microbiological products to efficiently collect samples of pathogens and biohazardous agents, has announced the discovery of what it calls "a...

Method for rapid diagnosis of Ebola hemorrhagic fever developed.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Researchers have developed a method for the rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-polymerase chain reaction (RT-PCR). According to recent research from the United...

Exotoxin components of Bacillus anthracis analyzed by Western blot.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Researchers have conducted a Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis. "The components of the Bacillus...

Monoclonal antibodies to B. anthracis capsular antigen developed.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Researchers have developed monoclonal antibodies to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. According to recent research published in the...

Arkansas hospitals, health-care systems get $5 million in federal money.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Arkansas has been allotted more than $5 million in federal money to prepare its hospitals and healthcare systems for bioterrorism, infectious diseases and natural disasters. The money is part of a...

Bioterrorism funding may be diverted from states.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- More than $55 million in federal bioterrorism preparedness money could be diverted from states to 21 of the nation's largest cities under a proposal before Congress. The U.S. Department of Health...

Boston leaders, health officials on lookout for signs of bioterrorism.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Doctors and public health officials hope to have an early warning system to detect signs of bioterrorism in place before thousands of Democrats descend on Boston for their national nominating...

Iowa receives $5.4 million for hospitals.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Iowa health officials will soon have an additional $5.4 million from the federal government to better prepare for bioterrorism attacks, infectious disease outbreaks and natural disasters. The U.S....

South Carolina places $650,000 order for TVI decontamination systems.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- TVI Corporation (TVIN) announced that the state of South Carolina has placed a $650,000 order for 42, 2-line TVI decontamination systems. The decision to select TVI systems was based on the need...

Ion-technology company announces 56% revenue growth for third quarter.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Implant Sciences Corp. (IMX) announced financial results for the 3 and 9 months ended March 31, 2004. For the 3 months ended March 31, 2004, the company recorded total revenues of $2,635,000 as...

New York City says nine police officers sue over World Trade Center toxins.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- New York City's law department said May 24, 2004, that all but 9 of the 1,700 rescue workers who filed health claims regarding toxins at the World Trade Center site withdrew the claims long ago. A...

DTAPS Protective suits certified for chemical/biological terrorism incidents.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Versar, Inc., (VSR) announced that its DTAPS (Disposable Toxicological Agent Protective System) Level B coverall chemical/biological protective suits are the first in the industry to be certified by...

Company readies sarin-gas neutralizing enzyme for first responders.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- Genencor International (GCOR) announced that it has manufactured research sample quantities of enzymes that will neutralize sarin gas and certain other organophosphate-based nerve agents. The...

The search for a safer smallpox vaccine: new data on promising candidate.
June 14, 2004... 2004 JUN 14 - (NewsRx.com & NewsRx.net) -- When used as an aerosolized weapon, smallpox could be controlled by a new vaccine under study at St. Louis University School of Medicine, according to new data. Detailed results from studies by Dr....

Handheld sensor offers anthrax detection capabilities for first responders.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- QTL Biosystems, LLC, announced a handheld sensor to detect anthrax, ricin, and other potential bioterrorism pathogens, for use by first responders, hospital triage personnel, Haz Mat personnel and...

Second U.S. patent granted for rapid microbe detection.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Electropure, Inc., (ELTP) announced that its subsidiary, Micro Imaging Technology (MIT), was granted a second U.S. patent for its laser-based technology that rapidly detects and identifies potentially...

Ohio hospitals will help monitor for signs of terrorist attack.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Hospitals in Ohio are joining with others to watch for signs of a terrorist attack, a move health officials say could play a vital role in early detection. Some Cincinnati and Columbus health care...

Current smallpox vaccine can be harmful to people with skin disorder.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Millions of Americans are at risk for a potentially deadly complication from smallpox vaccine known as eczema vaccinatum, or EV. EV occurs almost exclusively among people with a history of atopic...

Bio-filtration company reports 158% increase in revenues.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Emergency Filtration Products, Inc., (EFP, EMFP) reported net sales of $260,761 for the 3-month period ended March 31, 2004, versus $100,956 for the comparable year ago period. For the quarters...

FBI awards contract for DNA analysis.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Privately held California-based MicroFluidic Systems Inc. (MFSI) announced that the Federal Bureau of Investigation awarded a contract to the team of MAR, Incorporated and MicroFluidic Systems Inc....

Additional results from Europe available for TB test; kits shipped to China.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Medical Services International Inc. (Pinksheets: MSITF) announced that it has received additional European test results from its VScan TB rapid test kits. These results found that the VScan TB test...

International nanotechnology shores up European shareholder base.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Isonics Corporation (Nasdaq:ISON), and international nanotechnology company, announced that it is launching an initiative to leverage its European presence and broaden its shareholder base in the...

TVI Corporation names new chief financial officer.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- TVI Corporation (TVIN) announced that Karin McQuade has been named TVI's vice president, finance and chief financial officer. "Although Karin joined TVI only recently, she has already proven...

Mouse neurotoxicity test for vaccinia-based smallpox vaccines developed.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Researchers have developed a mouse neurotoxicity test for vaccinia-based smallpox vaccines. "The only Food & Drug Administration (FDA) licensed smallpox vaccine, Dryvax, was associated with rare...

Smallpox DNA vaccine protects primates against lethal monkeypox.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. "Two decades after a worldwide vaccination campaign was used to successfully eradicate naturally occurring smallpox, the...

New licensing agreement to create therapeutic vaccine platform.
June 21, 2004... 2004 JUN 21 - (NewsRx.com & NewsRx.net) -- Private biotechnology company Juvaris BioTherapeutics, Inc., announced that it has entered into an exclusive license agreement with Colorado State University (CSU) to develop therapeutic vaccines using...

CDC collaboration yields new test for anthrax.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- A new test funded by the U.S. Centers for Disease Control and Prevention (CDC) and developed in collaboration with a commercial partner has become the first test approved by the U.S. Food and Drug...

Public-private partnership extends Dutch-American cooperation in biodefense.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- IQ Corp., a biopharmaceutical company based in The Netherlands, and the U.S. Navy Medical Research Center (NMRC) have entered into a Cooperative Research and Development Agreement (CRADA) to develop...

Vaccines for the prevention of diseases caused by potential bioweapons.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Scientists review vaccines for the prevention of diseases caused by potential bioweapons in a recent issue of the journal Clinical Immunology. According to researchers in the United States, "The...

To defeat bioterrorism, more international collaboration is needed.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- A bioterrorist attack need not occur on U.S. soil to pose serious threats to the U.S. population, according to Tom May, PhD, a Medical College of Wisconsin bioethicist. SARS, for example, spread from...

NIH supports phase I clinical trial of DNA-based anthrax vaccine.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Vical, Inc., (VICL) announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) has advised the company it will support a phase I...

B. anthracis antigens for testing anthrax immunity identified.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Scientists have identified Bacillus anthracis extractable antigens that are suitable for testing anthrax immunity. According to published research from Israel, "Three extractable Bacillus...

Antimicrobial drug development declining.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Despite an increasing need for antimicrobial drugs, drug development in this area in the United States is declining. According to recent research published in the journal Clinical Infectious...

BioShield shortcomings subject of industry conference.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Despite the approval of $5.6 billion in federal funding for vaccines and treatments to fend off or respond to a bioterror attack, and efforts to streamline the approval process for those drugs, many...

Experts warn that gene research could be used for warfare.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Biotechnology research used to find new cures for disease could instead be harnessed for use as a weapon of terror, a prominent European think tank warned. The Stockholm International Peace...

Defense Department starts first responder tech center at Pitt.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- The Defense Department has chosen a University of Pittsburgh business laboratory to market technology that could benefit law enforcement, firefighters and emergency medical personnel responding to a...

MSSI-TeleScience receives $15M commitment.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- MSSI-TeleScience International, Inc., (MSSI) will use a portion of its recently acquired $15 million equity line of credit for new acquisitions. MSSI President and CEO Dr. B.B. Sahay said, "Our...

Dutch biopharma enters collaborative agreement with NMRC.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- IQ Corp. (IQC), a biopharmaceutical company based in the Netherlands, and the U.S. Navy Medical Research Center (NMRC) have formed a cooperative research and development agreement (CRADA) to develop...

Company announces genetic-detection advance in nature biotechnology.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Nanosphere, Inc., announced that researchers have developed a colorimetric detection capability for its nanoparticle-based molecular detection systems that will further simplify the identification of...

FDA certificate to export products to Japan granted for RespAide.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Emergency Filtration Products, Inc., (EFP, EMFP) announced that it had obtained a Certificate for Products for Export from the U.S. Food and Drug Administration (FDA) for its RespAide, Vapor Isolation...

UCSD partners with Peru in NIH grant to battle world's number 2 killer.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- In the middle of the Peruvian Amazon, a battle against malaria - the second largest killer of people worldwide - will be undertaken by an international team of researchers led by tropical disease...

Model for disease outbreaks in realistic urban networks developed.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- Scientists have developed a model for managing disease outbreaks in realistic urban social networks. "Most mathematical models for the spread of disease use differential equations based on...

Smallpox as biological weapon reviewed.
June 28, 2004... 2004 JUN 28 - (NewsRx.com & NewsRx.net) -- A researcher reviews the threat of smallpox as a biological weapon in a recent issue of the American Journal of Bioethics. "This article reviews the history of smallpox and ethical issues that...